CCR 20th Anniversary Commentary: Triple-Negative Breast Cancer in 2015-Still in the Ballpark

被引：11

作者：

Narod, Steven A. ^{[1
]}

Dent, Rebecca A. ^{[2
]}

Foulkes, William D. ^{[3
,4
]}

机构：

[1] Womens Coll Res Inst, Familial Breast Canc Res Unit, Toronto, ON, Canada

[2] Sunnybrook Hlth Sci Ctr, Dept Med Oncol, Toronto, ON M4N 3M5, Canada

[3] McGill Univ, Jewish Gen Hosp, Dept Human Genet, Montreal, PQ H3T 1E2, Canada

[4] McGill Univ, McGill Univ Hlth Ctr, Montreal, PQ H3T 1E2, Canada

来源：

CLINICAL CANCER RESEARCH | 2015年 / 21卷 / 17期

关键词：

NEOADJUVANT CISPLATIN; MUTATIONS;

D O I：

10.1158/1078-0432.CCR-14-3122

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The research article by Dent and colleagues, which was published in the August 1, 2007, issue of Clinical Cancer Research, provided a clinical description of metastatic progression of triple-negative breast cancers. Finding successful treatment strategies for women with triple-negative breast cancer remains a challenge. (C) 2015 AACR.

引用

页码：3813 / +

页数：2

共 50 条

[41] ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer
Punie, K.
Matikas, A.
ESMO OPEN, 2021, 6 (01)
[42] Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer
Li, Quan
Jin, Wenxu
Cai, Yefeng
Yang, Fang
Chen, Endong
Ye, Danrong
Wang, Qingxuan
Guan, Xiaoxiang
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 485 (03) : 693 - 697
[43] Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
Venetis, Konstantinos
Fusco, Nicola
Sajjadi, Elham
FRONTIERS IN ONCOLOGY, 2021, 11
[44] Design, synthesis and biological evaluation of CDC20 inhibitors for treatment of triple-negative breast cancer
Zhao, Shi-Fang
Leng, Jia-Fu
Xie, Shan -Shan
Zhu, Li-Qiao
Zhang, Meng -Yu
Kong, Ling-Yi
Yin, Yong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268
[45] A commentary on germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors
Kaname, Tadashi
JOURNAL OF HUMAN GENETICS, 2020, 65 (07) : 589 - 590
[46] A commentary on germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors
Tadashi Kaname
Journal of Human Genetics, 2020, 65 : 589 - 590
[47] Design, synthesis and optimization of Apcin analogues as Cdc20 inhibitors for triple-negative breast cancer therapy
Le, Xiangyang
Chen, Qingsong
Wen, Qiwan
Cao, Shuyang
Zhang, Lei
Hu, Liqing
Hu, Gaoyun
Li, Qianbin
Chen, Zhuo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 289
[48] Mesenchymallike immune-activated: the 4th robust triple-negative breast cancer molecular subtype
Campone, Mario
Jezequel, Pascal
Ben Azzouz, Fadoua
Gouraud, Wilfried
Bassevile, Agnes
Michel, Bertrand
Lasla, Hamza
Frenel, Jean Sebastien
CANCER RESEARCH, 2024, 84 (09)
[49] A phase Ib/II study of leronlimab combined with carboplatin in patients with CCR5+metastatic triple-negative breast cancer (mTNBC)
Cristofanilli, Massimo
Chittoria, Namita
Ehsani, Sima
Rui, Hallgeir
Dolezal, Milana
Stork-Sloots, Lisette
de Snoo, Femke
Recknor, Christopher
Abramson, Vandana
CANCER RESEARCH, 2022, 82 (04)
[50] Addressing Continued Disparities in Access to Breast Reconstruction on the 20th Anniversary of the Women's Health and Cancer Rights Act
Berlin, Nicholas L.
Wilkins, Edwin G.
Alderman, Amy K.
JAMA SURGERY, 2018, 153 (07) : 603 - 604

← 1 2 3 4 5 →